SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-16-004692
Filing Date
2016-04-18
Accepted
2016-04-18 16:11:58
Documents
5
Effectiveness Date
2016-04-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A adms-20160603xdefa14a.htm DEFA14A 43868
2 GRAPHIC adms20160603xdefa14a001.gif GRAPHIC 55198
3 GRAPHIC adms20160603xdefa14a002.gif GRAPHIC 103149
4 GRAPHIC adms20160603xdefa14a003.gif GRAPHIC 18044
5 GRAPHIC adms20160603xdefa14a004.gif GRAPHIC 4419
  Complete submission text file 0001558370-16-004692.txt   294394
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36399 | Film No.: 161577045
SIC: 2834 Pharmaceutical Preparations